These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37369238)

  • 1. Universal Urine Drug Screening with Rapid Confirmation upon Admission to Labor and Delivery.
    Haizler-Cohen L; Collins A; Kaplan DM; Giri P; Davidov A; Blau J; Fruhman G
    Am J Perinatol; 2024 Aug; 41(11):1512-1520. PubMed ID: 37369238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome?
    Gersch H; Shah D; Chroust A; Bailey B
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2211706. PubMed ID: 37183045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine Comprehensive Drug Screen, Low Birth Weight and Withdrawal Symptoms in a Neonatal Unit: A Case Control Study.
    Hon KL; Chan MH; Ng MH; Ho CC; Tsang KY; Tam WH; Ho CS
    Curr Clin Pharmacol; 2016; 11(4):274-281. PubMed ID: 27748174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in opioid withdrawal syndrome among neonates with intrauterine opioid exposure.
    Pourcyrous M; Elabiad MT; Rana D; Gaston KP; DeBaer L; Dhanireddy R
    Pediatr Res; 2021 Aug; 90(2):459-463. PubMed ID: 33214673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe Neonatal Opioid Withdrawal Requiring Pharmacotherapy: Impact of Region of Residence.
    Sankaran D; Rawat S; Kachelmeyer JL; Li ES; Reynolds AM; Rawat M; Chandrasekharan P
    Am J Perinatol; 2024 May; 41(S 01):e654-e663. PubMed ID: 35973797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression.
    Baldo BA
    Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Care-by-parent model as a tool for reduction of neonatal opioid withdrawal syndrome in neonates exposed to buprenorphine maintenance therapy in-utero.
    Lawlor ML; Shook LA; McQuerry K; Srinivasan A; Johnson QB; Chavan NR; Critchfield AS
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2718-2722. PubMed ID: 30563376
    [No Abstract]   [Full Text] [Related]  

  • 9. Understanding barriers to timely identification of infants at risk of neonatal opiate withdrawal syndrome.
    Howell MP; Smith AM; Lindsay EB; Drury SS
    J Matern Fetal Neonatal Med; 2021 Apr; 34(7):1161-1166. PubMed ID: 31195865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning.
    Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM
    JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An epidemiological examination of neonatal opioid withdrawal syndrome and maternal and infant characteristics.
    Schwartz AN; Meschke LL
    Arch Womens Ment Health; 2024 Oct; 27(5):863-867. PubMed ID: 38573341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal maternal drug testing in a high-prevalence region of prescription opiate abuse.
    Wexelblatt SL; Ward LP; Torok K; Tisdale E; Meinzen-Derr JK; Greenberg JM
    J Pediatr; 2015 Mar; 166(3):582-6. PubMed ID: 25454935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality.
    Grossarth S; Osmundson SS; Wiese AD; Phillips SE; Pham A; Leech AA; Patrick SW; Spieker AJ; Grijalva CG; Adgent MA
    JAMA Pediatr; 2023 Jul; 177(7):675-683. PubMed ID: 37155175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates and types of urine drug screen false negative results compared with confirmatory toxicology testing in major trauma patients.
    Weiss ST; Veach LJ; McGill W; Brent J
    Clin Toxicol (Phila); 2022 Oct; 60(10):1122-1129. PubMed ID: 36069771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Opioid and Stimulant Exposure In Utero Through Targeted and Untargeted Metabolomics Analysis of Umbilical Cords.
    Mamillapalli SS; Smith-Joyner A; Forbes L; McIntyre K; Poppenfuse S; Rushing B; Strom C; Danell AS; May L; Kuehn D; Kew K; Ravisankar S
    Ther Drug Monit; 2020 Oct; 42(5):787-794. PubMed ID: 32142018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
    Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
    JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome.
    Bhatt-Mehta V; Jing X; Wang X; Zhu HJ
    Pharmacotherapy; 2024 Jan; 44(1):22-27. PubMed ID: 37574548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
    Gray TR; Choo RE; Concheiro M; Williams E; Elko A; Jansson LM; Jones HE; Huestis MA
    Addiction; 2010 Dec; 105(12):2151-9. PubMed ID: 20854338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal Use of Medication for Opioid Use Disorder and Other Prescription Opioids in Cases of Neonatal Opioid Withdrawal Syndrome: North Carolina Medicaid, 2016-2018.
    Austin AE; Bona VD; Cox ME; Proescholdbell S; Fliss MD; Naumann RB
    Am J Public Health; 2021 Sep; 111(9):1682-1685. PubMed ID: 34383554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.